Le Lézard
Classified in: Health, Science and technology
Subject: VET

VA names NeuroFlow a finalist in $20 million Mission Daybreak grand challenge to reduce Veteran suicides


Healthcare technology company selected among 1,371 submissions as one of 30 finalists in Phase I

PHILADELPHIA, Sept. 21, 2022 /PRNewswire-PRWeb/ -- The U.S. Department of Veterans Affairs has named NeuroFlow as a finalist in Mission Daybreak ? a $20 million challenge designed to help VA develop new suicide prevention strategies for Veterans. As a finalist, NeuroFlow will receive $250,000 and advance to Phase 2 of the challenge.

Co-founded by a U.S. Army Veteran, NeuroFlow supports organizations in their efforts to improve behavioral health access and support for Veterans. Partners, including The Wounded Warrior Project, Stop Soldier Suicide, BraveHearts, can utilize the company's technology to provide Veterans with 24/7 access to confidential, personalized resources to support their overall wellness. "Properly supporting the behavioral health of our Veterans requires innovative, technology-driven solutions," notes Army Veteran and NeuroFlow's VP of Clinical Operations Matt Miclette. "The efforts of Mission Daybreak align directly with the DNA and mission of NeuroFlow; we're honored to be a part of this challenge and join a diverse group of organizations tackling the issue of Veteran suicide."

During Phase 2 of the challenge, 30 finalists will join a virtual accelerator program designed to help the finalists develop ambitious, but achievable roadmaps for prototyping, iteration, testing, and evaluation. Technology partners supporting the accelerator include Amazon and Microsoft.

In November 2022, finalists will present their solutions to key stakeholders, investors, and partners at Demo Day, a live pitch event. Phase 2 will award $11.5 million in prizes:

 

Visit missiondaybreak.net for more information on the challenge. Subscribe to the Mission Daybreak newsletter to follow along with the finalists' progress and receive updates on Demo Day. Reporters covering this issue can download VA's Safe Messaging Best Practices fact sheet or visit ReportingOnSuicide.org for important guidance on how to communicate about suicide.

About NeuroFlow: NeuroFlow integrates behavioral health across the care continuum by assessing and triaging people to get them to the right level of care, providing high-tech and high-touch support for populations that would typically fall through the cracks in today's healthcare system. Proven to drive better clinical and financial outcomes for leading health systems, payors, and the Department of Defense covering 15 million lives, NeuroFlow's platform combines consumer engagement with enterprise-level care management software and clinical support services to support integrated behavioral health at scale. To learn more, visit http://www.neuroflow.com.

Media Contact

Anthony Stipa, NeuroFlow, +1 (610) 420-1724, [email protected]

Twitter

 

SOURCE NeuroFlow


These press releases may also interest you

at 12:45
Leading research and experience management firm Sogolytics has released an original study examining the telehealth landscape, highlighting its achievements and challenges in providing positive experiences for patients. "It's critical for providers...

at 12:24
West Physics Consulting, LLC ("West Physics"), the leading national provider of integrated medical and health physics services, announced today that it has completed the purchase of the medical physics service division of Tricord, Inc. ("Tricord"), a...

at 12:16
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...

at 12:08
Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its...

at 12:06
Burrell College of Osteopathic Medicine (BCOM) attained the highest level of accreditation from the American Osteopathic Association (AOA) Commission on Osteopathic College Accreditation (COCA). Burrell has been awarded the prestigious accreditation...

at 12:05
Radiance Biopharma ("Radiance" or the "Company"), a biopharmaceutical company specializing in the development of novel Antibody Drug Conjugates (ADCs) and Bispecific ADCs (BsADCs) treatments for cancers, today announced that...



News published on and distributed by: